RedChip Companies
|
Weekly Newsletter
|
|
|
Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
|
Reviva Pharmaceuticals (Nasdaq: RVPH), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, announced positive topline results and successful completion of its pivotal Phase 3 RECOVER trial evaluating the efficacy, safety and tolerability of once-daily brilaroxazine, a serotonin-dopamine signaling modulator in adults with schizophrenia. The trial successfully met its primary endpoint, with brilaroxazine at the 50 mg dose achieving a statistically significant and clinically meaningful 10.1-point reduction in Positive and Negative Syndrome Scale (PANSS) total score compared to placebo (-23.9 brilaroxazine 50 mg vs. -13.8 placebo, p<0.001) at week 4. Brilaroxazine also achieved statistically significant and clinically meaningful reductions in all major symptom domains and secondary endpoints at week 4 with the 50 mg dose vs. placebo. The 15 mg dose of brilaroxazine was numerically superior to placebo on the primary endpoint and most secondary endpoints and reached statistical significance on two key secondary endpoints.
For more information, visit www.revivapharma.com
|
ASP Isotopes Enters Strategic Relationship with PET Labs Pharmaceuticals for the Distribution of Medical Isotopes
ASP Isotopes (Nasdaq: ASPI), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple industries, announced that it has entered into a strategic relationship with PET Labs for the production and distribution of medical isotopes. PET Labs is a South African radiopharmaceutical operations company dedicated to nuclear medicine and the science of radiopharmaceutical production. PET Labs focuses on the production of fluorinated radioisotopes and active pharmaceutical ingredients.
|
American Resources Corporation's ReElement Technologies Produces Ultra-High Purity, 99.96%, Battery-Grade Lithium from Spodumene Bearing Pegmatite Ore
American Resources Corporation (Nasdaq: AREC) subsidiary, ReElement Technologies Corporation ("ReElement"), a leading provider of high-performance refining capacity of rare earth and critical battery elements, announced that it has achieved an ultra-high purity of 99.96% battery-grade lithium carbonate (Li2CO3) from its exclusively licensed and patented multi-modal chromatography technology that was developed in partnership with Purdue University. The results were produced from hard rock, spodumene bearing pegmatite ore and showcase the technology's ability to provide industry-best purity results across various feedstocks, both primary and recycled.
|
|
|
1847 Holdings’ Subsidiary 1847 Cabinets Announces Expanded Relationship with One of the Nation’s Leading Home Builders
1847 Holdings (NYSE American: EFSH), a unique holding company that combines the attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, announced that its subsidiary, 1847 Cabinets Inc., a designer, manufacturer and installer of cabinets, doors and millwork for residential construction, entered into an expanded agreement with one of the nation's largest homebuilders as its exclusive provider of windows for all new residential construction projects in the Reno, Nevada, metropolitan area.
|
American Acquisition Opportunity Inc. Closes Previously Announced Acquisition of Royalty Management Corporation
American Acquisition Opportunity (Nasdaq: AMAO) closed its previously announced acquisition of Royalty Management Co, a royalty company building shareholder value to benefit both our shareholders and communities by acquiring and developing high value assets in a sustainable market environment. Concurrent with the business combination, the Company was renamed "Royalty Management Holding Corporation." The resulting company will continue to be based in Fishers, Indiana and will be led by a diverse board of innovators in mineral, agriculture, natural resources, intellectual property and energy transition sectors.
|
|
|
Small Stocks Big Money™ Podcasts
|
|
|
Upcoming Events |
|
|
|
OTC: ARDS - Aridis Pharmaceuticals |
4:15pm Eastern |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
Archive Events |
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 46 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Lesson of the Week
Don't wait till you have all the answers. Jump in and adjust course as you go.
|
|
|
MidSouth Week in Review
Bitcoin surged to $31k from $26k in early October. Gold hit $2000 from $1830 early in the month.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|